The Union of Concerned Scientists (UCS) has unveiled an interactive tool geared toward documenting and highlighting the different ways through which science has come under attack…
Scientists have for long been concerned about why some people with liver cancer respond when given immunotherapy but others don’t. A recent comprehensive review provides key…
Deal activity remains strong in antibody-drug conjugates (ADCs) and T-cell engager (TCE) therapeutics, with pharmaceutical companies continuing to commit substantial…
Disseminated on behalf of MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) and may include paid advertising. MindBio kiosks use artificial intelligence and…
Disseminated on behalf of Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) and may include paid advertising. Quantum BioPharma executive co-chairman and co-founder…
Researchers at University of Washington have discovered that a drug that is currently approved by the FDA could help in boosting the…
Advances in digital health, cloud computing and data analytics are making it possible to move beyond episodic monitoring toward a…
Disseminated on behalf of Onco-Innovations Ltd. (CBOE CA: ONCO) (OTCQB: ONNVF) and may include paid advertising. Onco-Innovations is advancing a new class of DNA Damage…
Cardio Diagnostics has positioned the science of epigenetics at the center of its diagnostic platform. Looking at an individual person’s…
For decades, cardiovascular risk assessment has centered on a checklist of factors never designed to capture the full biological picture…